MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.
Anticancer Res
; 22(2B): 1205-8, 2002.
Article
em En
| MEDLINE
| ID: mdl-12168926
ABSTRACT
BACKGROUND:
Magnetic resonance spectroscopy (MRS) is a new diagnostic tool which allows the detection of cellular metabolites. We assessed the usefulness of single- voxel MRS diagnosis for localization of prostate cancer. PATIENTS ANDMETHODS:
The study population consisted of 10 patients with prostate cancer. We set I or 2 voxels at the peripheral zone (PZ) of the prostate where biopsy had confirmed adenocarcinoma. MRS provided metabolic information about citrate, creatine and choline levels. We calculated the ratio of these metabolites ([choline + creatine]/citrate) and judged areas where the metabolic ratio was greater than 0.86 as positive.RESULTS:
Thirteen out of 19 voxels showed a cancer pattern which indicated a high choline peak and low citrate peak The accuracy, sensitivity and specificity of MRS diagnosis of tumor localization were 84.2%, 81.3% and 100%, respectively.CONCLUSION:
MRS is useful for the diagnosis of prostate cancer localization.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Adenocarcinoma
Tipo de estudo:
Diagnostic_studies
Limite:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Anticancer Res
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Japão